Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7449184 Fixed dosing of HER antibodies

Patent 7449184 was granted and assigned to Genentech on November, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74491840

Patent Inventor Names

Rene Bruno0

Jian-Feng Lu0

Chee M. Ng0

David E. Allison0

Date of Patent

November 11, 2008

Patent Application Number

111540910

Date Filed

June 15, 2005

Patent Citations Received

‌

US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer

‌

US Patent 11654105 Subcutaneous HER2 antibody formulations

‌

US Patent 11655305 Treatment of metastatic breast cancer

‌

US Patent 11872289 Anti-MUC1 antibody-drug conjugate

‌

US Patent 11945882 Method for producing antibody-drug conjugate

‌

US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer

‌

US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof

Patent Primary Examiner

‌

Larry R. Helms

Patent abstract

The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7449184 Fixed dosing of HER antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API